Cargando…
Lansoprazole is an antituberculous prodrug targeting cytochrome bc(1)
Better antibiotics capable of killing multi-drug-resistant Mycobacterium tuberculosis are urgently needed. Despite extensive drug discovery efforts, only a few promising candidates are on the horizon and alternative screening protocols are required. Here, by testing a panel of FDA-approved drugs in...
Autores principales: | Rybniker, Jan, Vocat, Anthony, Sala, Claudia, Busso, Philippe, Pojer, Florence, Benjak, Andrej, Cole, Stewart T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Pub. Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4510652/ https://www.ncbi.nlm.nih.gov/pubmed/26158909 http://dx.doi.org/10.1038/ncomms8659 |
Ejemplares similares
-
New 2-Ethylthio-4-methylaminoquinazoline derivatives inhibiting two subunits of cytochrome bc1 in Mycobacterium tuberculosis
por: Lupien, Andréanne, et al.
Publicado: (2020) -
No Evidence for Acquired Mutations Associated with Cytochrome bc(1) Inhibitor Resistance in 13,559 Clinical Mycobacterium tuberculosis Complex Isolates
por: Rybniker, Jan, et al.
Publicado: (2018) -
Essential Nucleoid Associated Protein mIHF (Rv1388) Controls Virulence and Housekeeping Genes in Mycobacterium tuberculosis
por: Odermatt, Nina T., et al.
Publicado: (2018) -
Antituberculous Serum
Publicado: (1899) -
On Treatment with Antituberculous Serum
Publicado: (1904)